Ratio Therapeutics and PharmaLogic Expand Manufacturing Collaboration for Radiopharmaceutical Clinical Development Tilray Q1 2026 Earnings EPS Miss Deepens as Losses Widen Revenue Details Omitted HEICO NYSE HEI Reports Record Revenue and EPS in Q2 2026 Amid Strong Demand TSLA Q1 2026 Earnings EPS Beats Estimates by 867 Amid Revenue Concerns CMPR Q1 2026 Earnings Stellar EPS Beat Drives Investor Optimism Despite Stock Pullback American Woodmark Corporation AMWD Q1 2026 Earnings EPS Surges 60 Above Estimates Revenue Data Unavailable RY Q1 2026 Earnings EPS Beats Estimates Revenue Not Disclosed SIF Q4 2001 Earnings EPS Misses Estimates by Wide Margin Stock Declines KZIA Q1 2026 Earnings WiderThanExpected Loss Despite Stock Rally ARL Q3 2024 Earnings Net Loss of 108 per Share Amid Challenging Real Estate Market SKYT Q1 2026 Earnings EPS Misses Estimates But Stock Gains 288